Merck and Pfizer Produce Promising Pills to Help End Pandemic
A potential gamechanger for the pandemic, Merck and Pfizer recently announced that each has developed an oral COVID-19 antiviral therapy and is seeking Emergency Use Authorization from the FDA. Pfizer's medication is called Paxlovid, and Merck's is molnupivravir. While vaccination remains the most important tool to curb the pandemic, these drugs could finally offer a viable treatment option for the infected.
Currently, limited treatment options are available. One such treatment, monoclonal antibodies, must be administered by IV or injection, requiring patients to travel to a hospital or infusion...